In the assessment of differential diagnostic accuracy, APF-HMMR, HMMR-NXPH4 and HMMR-PITX1 duos show better AUC, sensitivity, specificity, accuracy and other values in patients with HCC or eHCC compared with non-tumor cases (Table 2). This evidence concerns the gene PITX1 and neoplasm.